Invariant NK T cells: potential for immunotherapeutic targeting with glycolipid antigens.

Van Kaer L, Parekh VV, Wu L
Immunotherapy. 2011 3 (1): 59-75

PMID: 21174558 · DOI:10.2217/imt.10.85

MeSH Terms (15)

Animals Antigen Presentation Antigens Autoimmune Diseases Clinical Trials as Topic Galactosylceramides Glycolipids Humans Immunotherapy Infections Mice Mice, Inbred C57BL Natural Killer T-Cells Neoplasms Treatment Outcome

Connections (2)

This publication is referenced by other Labnodes entities:

Links